Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

High B Value Diffusion and Stroke

NCT: NCT03923439 · COMPLETED

NCT IDNCT03923439
StatusCOMPLETED
Start Date2019-04-01
Completion2022-06-21
SponsorUniversity Hospital, Bordeaux (OTHER)
First posted
Last updated

Brief Summary

This study will include 100 stroke patients with significant penumbra at the acute stage and successfully recanalized thanks to thrombectomy, intravenous thrombolysis or spontaneously. Patients will be explored with the multi-b diffusion sequence on a new 3T research magnet equipped with high gradient system. In this project the investigators hypothesize that diffusion MRI at high and ultra-high b-values could be sensitive enough to quantify selective neuronal loss in the rescued penumbra and to study its relationship with the initial hypoperfusion and its impact in terms of clinical recovery.

Frequently Asked Questions

What is High B Value Diffusion and Stroke?

High B Value Diffusion and Stroke is a clinical trial registered under NCT03923439. Current status: COMPLETED.

What is the status of NCT03923439?

The current status of NCT03923439 (High B Value Diffusion and Stroke) is: COMPLETED.

When did High B Value Diffusion and Stroke start?

High B Value Diffusion and Stroke started on 2019-04-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.